Major role of levofloxacin in the treatment of a case of Listeria monocytogenes meningitis

Diagnostic Microbiology and Infectious Disease

Volumn 58, Issue 1, 2007, Pages 137-139

  Viale, Pierluigi ^a   Furlanut, Mario ^b   Cristini, Francesco ^a   Cadeo, Barbara ^a   Pavan, Federica ^b   Pea, Federico ^b  

^a Medical School   (Italy)

^b University Medical School   (Italy)

Author keywords

CSF; Levofloxacin; Listeria monocytogenes; Meningitis

Indexed keywords

CEFOTAXIME; DEXAMETHASONE; MEROPENEM;

AGED; ALCOHOL ABUSE; ARTICLE; BACTERIAL MENINGITIS; BORDERLINE HYPERTENSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS DISORDER; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOTRACHEAL INTUBATION; FEMALE; FEVER; GLASGOW COMA SCALE; HUMAN; HYPERGLYCEMIA; LEUKOCYTOSIS; LISTERIA MONOCYTOGENES; LUMBAR PUNCTURE; PRIORITY JOURNAL; RESPIRATORY ALKALOSIS; TACHYCARDIA; TACHYPNEA;

AGED; ANTI-BACTERIAL AGENTS; CEREBROSPINAL FLUID; FEMALE; HUMANS; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MENINGITIS, LISTERIA; OFLOXACIN; TREATMENT OUTCOME;

EID: 34247856024     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.11.010     Document Type: Article

References (12)

1. Cormican M.G., and Jones R.N. Antimicrobial activity of cefotaxime tested against infrequently isolated pathogenic species (unusual pathogens). Diagn. Microbiol. Infect. Dis. 22 (1995) 43-48
2. Flatz L., Cottagnoud M., Kuhn F., Entenza J., Stucki A., and Cottagnoud P. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci. J. Antimicrob. Chemother. 53 (2004) 305-310
3. Grumbach N.M., Mylonakis E., and Wing E.J. Development of listerial meningitis during ciprofloxacin treatment. Clin. Infect. Dis. 29 (1999) 1340-1341
4. Kuhn F., Cottagnoud M., Acosta F., Flatz L., Entenza J., and Cottagnoud P. Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro. Antimicrob. Agents Chemother. 47 (2003) 2487-2491
5. Lipman J., Allworth A., and Wallis S.C. Cerebrospinal fluid penetration of high doses of intravenous ciprofloxacin in meningitis. Clin. Infect. Dis. 31 (2000) 1131-1133
6. Martinez-Martinez L., Pascual A., Suarez A.I., and Perea E.J. In-vitro activity of levofloxacin, ofloxacin and d-ofloxacin against coryneform bacteria and Listeria monocytogenes. J. Antimicrob. Chemother. 43 Suppl C (1999) 27-32
7. Pea F., Pavan F., Nascimben E., Benetton C., Scotton P.G., Vaglia A., and Furlanut M. Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy. Antimicrob. Agents Chemother. 47 (2003) 3104-3108
8. Scotton P.G., Pea F., Giobbia M., Baraldo M., Vaglia A., and Furlanut M. Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis. Clin. Infect. Dis. 33 (2001) e109-e111
9. Seral C., Barcia-Macay M., Mingeot-Leclercq M.P., Tulkens P.M., and Van Bambeke F. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages. J. Antimicrob. Chemother. 55 (2005) 511-517
10. Siegman-Igra Y., Levin R., Weinberger M., Golan Y., Schwartz D., Samra Z., Konigsberger H., Yinnon A., Rahav G., Keller N., Bisharat N., Karpuch J., Finkelstein R., Alkan M., Landau Z., Novikov J., Hassin D., Rudnicki C., Kitzes R., Ovadia S., Shimoni Z., Lang R., and Shohat T. Listeria monocytogenes infection in Israel and review of cases worldwide. Emerg. Infect. Dis. 8 (2002) 305-310
11. Tunkel A.R., Hartman B.J., Kaplan S.L., Kaufman B.A., Roos K.L., Scheld W.M., and Whitley R.J. Practice guidelines for the management of bacterial meningitis. Clin. Infect. Dis. 39 (2004) 1267-1284
12. van Ogtrop M.L., Mattie H., Sekh B.R., van Strijen E., and van Furth R. Comparison of the antibacterial efficacies of ampicillin and ciprofloxacin against experimental infections with Listeria monocytogenes in hydrocortisone-treated mice. Antimicrob. Agents Chemother. 36 (1992) 2375-2380